HomeCompareCLIFF vs MRK

CLIFF vs MRK: Dividend Comparison 2026

CLIFF yields 2902.76% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLIFF wins by $54.12M in total portfolio value
10 years
CLIFF
CLIFF
● Live price
2902.76%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$54.17M
Annual income
$769,585.52
Full CLIFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CLIFF vs MRK

📍 CLIFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLIFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLIFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLIFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLIFF
Annual income on $10K today (after 15% tax)
$246,734.40/yr
After 10yr DRIP, annual income (after tax)
$654,147.69/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CLIFF beats the other by $645,819.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLIFF + MRK for your $10,000?

CLIFF: 50%MRK: 50%
100% MRK50/50100% CLIFF
Portfolio after 10yr
$27.12M
Annual income
$389,691.83/yr
Blended yield
1.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CLIFF
No analyst data
Altman Z
0.7
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLIFF buys
0
MRK buys
0
No recent congressional trades found for CLIFF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLIFFMRK
Forward yield2902.76%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$54.17M$56.8K
Annual income after 10y$769,585.52$9,798.13
Total dividends collected$39.43M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CLIFF vs MRK ($10,000, DRIP)

YearCLIFF PortfolioCLIFF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$155,838$145,137.88$11,206$366.19+$144.6KCLIFF
2$1,223,661$1,056,914.95$12,650$502.35+$1.21MCLIFF
3$5,187,378$3,878,059.96$14,407$694.19+$5.17MCLIFF
4$13,232,725$7,682,230.47$16,585$967.82+$13.22MCLIFF
5$23,316,474$9,157,458.53$19,342$1,363.89+$23.30MCLIFF
6$32,488,687$7,540,059.71$22,913$1,947.19+$32.47MCLIFF
7$39,672,316$4,909,421.22$27,662$2,823.89+$39.64MCLIFF
8$45,250,758$2,801,379.33$34,159$4,173.35+$45.22MCLIFF
9$49,911,437$1,493,125.96$43,337$6,308.80+$49.87MCLIFF
10$54,174,823$769,585.52$56,776$9,798.13+$54.12MCLIFF

CLIFF vs MRK: Complete Analysis 2026

CLIFFStock

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. The company operates through two segments, Banking and Diagnostics. It provides cord blood, cord lining, and cord tissue banking services comprising processing and storage of stem cells; and non-invasive prenatal testing, paediatric vision screening, newborn metabolic screening, and newborn genetic screening services. The company also offers preimplantation genetic screening, endometrial receptivity test, paediatric allergen test, and genetic talent test services, as well as moms up, a mobile app for pregnancy and parenting resources. In addition, it provides management, marketing, and property investment services. Cordlife Group Limited was incorporated in 2001 and is headquartered in Singapore.

Full CLIFF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CLIFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLIFF vs SCHDCLIFF vs JEPICLIFF vs OCLIFF vs KOCLIFF vs MAINCLIFF vs JNJCLIFF vs ABBVCLIFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.